Los Angeles Prospective GI Biliary and EUS Series
Prospective Evaluation of Pancreatic, Biliary, and Gastrointestinal Neoplasia by Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS)
Sponsor: University of Southern California
Listed as NCT02196935, this observational or N/A phase trial focuses on Biliary Disease and Gastrointestinal Neoplasms and remains ongoing. Sponsored by University of Southern California, it has been updated 12 times since 2010, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2022 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Oct 2021 — Jul 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Jun 2019 — Jan 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
May 2019 — Jun 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .